Biotricity, Inc. (BTCY)

USD 0.5

(2.04%)

Long Term Debt Summary of Biotricity, Inc.

  • Biotricity, Inc.'s latest annual long term debt in 2024 was 10.85 Million USD , down -16.81% from previous year.
  • Biotricity, Inc.'s latest quarterly long term debt in 2024 FY was 10.85 Million USD , down -24.8% from previous quarter.
  • Biotricity, Inc. reported annual long term debt of 14.43 Million USD in 2023, up 6.12% from previous year.
  • Biotricity, Inc. reported annual long term debt of 13.6 Million USD in 2022, up 3567.7% from previous year.
  • Biotricity, Inc. reported quarterly long term debt of 13.77 Million USD for 2024 Q1, down -4.21% from previous quarter.
  • Biotricity, Inc. reported quarterly long term debt of 10.85 Million USD for 2024 FY, down -24.8% from previous quarter.

Annual Long Term Debt Chart of Biotricity, Inc. (2024 - 2014)

Historical Annual Long Term Debt of Biotricity, Inc. (2024 - 2014)

Year Long Term Debt Long Term Debt Growth
2024 10.85 Million USD -16.81%
2023 14.43 Million USD 6.12%
2022 13.6 Million USD 3567.7%
2021 370.9 Thousand USD 550.07%
2020 57.05 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%

Peer Long Term Debt Comparison of Biotricity, Inc.

Name Long Term Debt Long Term Debt Difference
Acutus Medical, Inc. 32.65 Million USD 66.755%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 3.25 Million USD -233.157%
Nemaura Medical Inc. 3.08 Million USD -251.589%
PetVivo Holdings, Inc. 1.01 Million USD -967.51%
RetinalGenix Technologies Inc. - USD -Infinity%
Sonendo, Inc. 14.03 Million USD 22.652%
Telesis Bio, Inc. 5.26 Million USD -106.032%
Talis Biomedical Corporation 16.78 Million USD 35.328%
Viveve Medical, Inc. 5.12 Million USD -111.862%